Lung Cancer Trials Ask AI to find trials
UnknownPhase 1 / Phase 2NCT03560362
Official study title

Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

Study summary

Randomized trial of intraoperative intercostal block with bupivacaine with epinephrine compared to lipossomal extended release bupivacaine.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedBupivacaine liposome and Bupivacaine / Epinephrine

The study team can explain what participation involves.

Who it may be forPain, Postoperative · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 20, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 1 / Phase 2

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Tennessee

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 1 / Phase 2
Sponsor
University of Tennessee
Interventions being studied
Drug: Bupivacaine liposome; Drug: Bupivacaine / Epinephrine
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Study topics
After surgery (adjuvant)→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patients who will be undergoing minimally invasive thoracic surgery
  • Patients who will be undergoing minimally invasive thoracic surgery
Reasons someone may not be able to joinExclusion criteria
  • Open surgery
  • Chronic use of narcotics
  • Use of pregabalin or similar
  • Significant liver or kidney dysfunction

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Methodist University HospitalMemphis, Tennessee

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 20, 2018. Always confirm current availability with the study team.

View original record ↗